USA Financial Formulas Lowers Stock Holdings in CVS Health Corporation $CVS

USA Financial Formulas reduced its holdings in CVS Health Corporation (NYSE:CVS) by 68.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,464 shares of the pharmacy operator’s stock after selling 14,254 shares during the period. USA Financial Formulas’ holdings in CVS Health were worth $487,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in CVS. Avion Wealth increased its holdings in CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares in the last quarter. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health in the second quarter valued at about $30,000. Bell Investment Advisors Inc increased its stake in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares in the last quarter. Front Row Advisors LLC raised its position in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares during the last quarter. Finally, Roxbury Financial LLC lifted its stake in CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 202 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on CVS shares. Truist Financial set a $100.00 price objective on CVS Health in a research note on Wednesday, December 10th. Jefferies Financial Group boosted their price target on CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. TD Cowen increased their price objective on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, December 10th. Argus lifted their target price on shares of CVS Health from $80.00 to $91.00 and gave the stock a “buy” rating in a research note on Tuesday, November 4th. Finally, Morgan Stanley increased their target price on shares of CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.67.

CVS Health Stock Down 0.1%

Shares of CVS opened at $77.70 on Friday. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The stock has a fifty day simple moving average of $79.09 and a two-hundred day simple moving average of $72.43. The company has a market capitalization of $98.63 billion, a PE ratio of 204.47, a price-to-earnings-growth ratio of 0.77 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same quarter in the prior year, the firm posted $1.09 earnings per share. CVS Health’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.